These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 31565986)
1. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population. Harris J; Phillips JD Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986 [TBL] [Abstract][Full Text] [Related]
2. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas. Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620 [TBL] [Abstract][Full Text] [Related]
3. Oral propranolol for parotid infantile hemangiomas. Li G; Xu DP; Sun HL; Cheng C; Liu ZM; Xi SL; Wang XK J Craniofac Surg; 2015 Mar; 26(2):438-40. PubMed ID: 25692890 [TBL] [Abstract][Full Text] [Related]
4. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas. Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438 [TBL] [Abstract][Full Text] [Related]
5. Use of propranolol for parotid hemangioma. Chang L; Jin Y; Lv D; Ying H; Wang T; Qiu Y; Ma G; Chen H; Yu W; Yang X; Lin X Head Neck; 2016 Apr; 38 Suppl 1():E1730-6. PubMed ID: 26676449 [TBL] [Abstract][Full Text] [Related]
6. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas. Moyakine AV; Herwegen B; van der Vleuten CJM J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436 [TBL] [Abstract][Full Text] [Related]
7. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695 [TBL] [Abstract][Full Text] [Related]
8. Propranolol in the Treatment of Infantile Hemangiomas: A Meta-Analysis in Chinese Patients. Li LL; Yan L; Luo MX; Cai YX; Mi XB; Zhang TD Pediatr Dermatol; 2015; 32(5):e210-4. PubMed ID: 26060892 [TBL] [Abstract][Full Text] [Related]
9. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes. Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699 [TBL] [Abstract][Full Text] [Related]
11. Predictors of poor response to oral propranolol in infantile hemangiomas. Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367 [TBL] [Abstract][Full Text] [Related]
12. [Intralesional Pingyangmycin therapy for 51 infantile patients with parotid gland hemangiomas]. Wang LL; Gao QH; Liu K; Wang XY; Wang CM; Wen YM Shanghai Kou Qiang Yi Xue; 2009 Apr; 18(2):142-6. PubMed ID: 19417988 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study. Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521 [TBL] [Abstract][Full Text] [Related]
15. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol. Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831 [TBL] [Abstract][Full Text] [Related]
16. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311 [TBL] [Abstract][Full Text] [Related]
17. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study. Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973 [TBL] [Abstract][Full Text] [Related]
18. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic. Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306 [TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. López-Gutiérrez JC Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264 [TBL] [Abstract][Full Text] [Related]